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758context of overall plaque burden in CV risk
prediction.
2. Intravascular ultrasound (IVUS) has been the
predominant invasive imaging modality used to
ascertain plaque features. The spatial resolution
of IVUS (w150 mm) is insufﬁcient for the diagnosis
of pathological thin-cap ﬁbroatheroma (TCFA;
ﬁbrous cap of 65 to 80 mm). Therefore, the limited
predictive ability of IVUS to identify TFCAs may
have contributed to imprecision in the character-
ization of lesion morphological changes over time.
Virtual histology and integrated backscatter IVUS
techniques have been developed to provide addi-
tional insight into individual plaque risk stratiﬁca-
tion by providing information about the spatial
distribution of various plaque tissue types (i.e.,
lipid, ﬁbrous, calciﬁc, etc.). Unfortunately, the
spatial resolution of backscatter-based IVUS tech-
niques remains limited, and the ability to accu-
rately distinguish various plaque tissues when
compared with real histology is questionable.
3. Most plaque ruptures are subclinical but these
events may be a principal mechanism underlying
plaque progression and, ultimately, the develop-
ment of plaque burden. Disregarding rupture-
prone plaque risks ignoring the pathophysiolog-
ical substrate for plaque progression, and ulti-
mately increases in plaque burden.
In conclusion, with the existing, although imper-
fect, evidence on vulnerable plaque from various
clinical studies, there is ample space for debating the
predictive value of vulnerable plaque identiﬁcation.
However, promoting the concept of the vulnerable
plaque as a myth may hinder further research capable
of obtaining novel insights into the transformation of
subclinical plaque rupture into manifest athero-
thrombosis, and limiting the accumulation of knowl-
edge that may shed light on mechanisms of plaque
progression. In the absence of evidence, we should
not assume evidence of absence in the role of high-
risk plaque in the genesis of atherothrombotic events.*Mazen S. Albaghdadi, MD, MS
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Absence of Evidence or Evidence of AbsenceWe thank Drs. Albaghdadi and Muse for extending
our discussion on the merit of detecting “vulnerable
plaques” by imaging. We agree with Albaghdadi and
Muse that we should not neglect a potential role of
individual plaque imaging in our risk assessment of
patients. As we discussed in our article, identifying
certain plaque characteristics may improve our ac-
curacy of risk prediction. Our intent was to empha-
size, however, that there is overwhelming evidence—
using various tools of assessment—in regard to the
strong relationship between the burden of athero-
sclerotic disease and risk of myocardial infarction and
death (1) compared with the much weaker data on
“vulnerable plaques” in this context. Indeed, none of
the papers listed by Albaghdadi and Muse in support
of “vulnerable plaque” risk prediction adjusted for
plaque burden: Puchner et al. (2) merely adjusted for
stenosis severity. Furthermore, major adverse car-
diovascular events in the study by Stone et al. (3) —as
discussed in our paper—are composed almost exclu-
sively of “soft” events, which should not be compared
with predicting death as is the case with most of the
studies listed for plaque burden. Current evidence
suggests the atherosclerotic plaque volume is the
predominant factor for determining risk of myocar-
dial infarction and death, whereas speciﬁc plaque
characteristics may have a modifying effect. It is
unclear at present which individual plaque features
are most useful for this purpose and whether such
assessment is of clinical value. Furthermore, the
“vulnerable” characteristics of a given plaque should
not be seen out of context of the patient’s speciﬁc
milieu. The fate of a plaque rupture largely depends
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759on the patient’s vulnerability—which is often neglec-
ted in our considerations of patients’ risk of adverse
events. The “protecting” effect of dense calcium
found by Criqui et al. (4) indeed may be interpreted as
a marker for individuals who are resistant to vascular
thrombosis in response to plaque ruptures and thus
exhibit more features of plaque healing/organization
in the absence of events. The PESA (Progression of
Early Subclinical Atherosclerosis) study found sub-
clinical atherosclerotic disease in 63% of participants
within a middle-aged cohort (5). The discussion on
risk assessment in patients warrants a broader,
comprehensive view rather than focusing on indi-
vidual plaque components.*Armin Arbab-Zadeh, MD, PhD, MPH
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and Cancer Risk of
Staff Working With
Fluoroscopically Guided
ProceduresWe took great interest in the paper by Orme et al. (1)
recently published in the Journal; however, we have
some concerns regarding the statistical analysis.As the authors noted, it has already been indi-
cated that the incidence of musculoskeletal pain is
associated with higher case volumes and more years
in practice for interventional cardiologists. In other
words, the total time exposed to a radiation-bearing
lead apron might lead to increased risk of musculo-
skeletal pain. Therefore, it is essential to investigate
the association between the total radiation exposure
time (self-reported exposure time per week  years in
the current profession) and the proportion of work-
related pain. Similarly, the association between the
total time of wearing a lead apron (time per week 
years in the current profession) and the proportion of
work-related pain also should be analyzed. Unfortu-
nately, years in current profession was not integrated
into the analysis when the authors investigated the
factors associated with increase of work-related pain.
As a result, this led to some cumbersome and feeble
explanations, such as constant and different physical
stress to argue why nonphysician employees in the
interventional lab reported a higher prevalence of
work-related musculoskeletal pain, even if they were
younger with fewer working years. If the authors
investigated the association between musculoskeletal
pain and the total time the catheterization lab oper-
ators and staff wore a radiation-bearing lead apron,
they might have been to obtain evidence to clarify the
issue. Moreover, it might have been more interesting
to investigate whether there is any correlation
between the pain score and the total time of wearing
a lead apron in participants exposed to radiation
without taking a pain medication.
In this cross-sectional case-control study, the au-
thors identiﬁed no difference in cancer prevalence
between groups (9% vs. 9%; p ¼ 0.96). We suspect a
signiﬁcant bias within this analysis because many
staff involved in procedures with radiation exposure
had fewer working years and less cancer risk, exhib-
iting a linear/linear-quadratic, no-threshold radiation
relationship with stochastic effects (2). Thus, the
comparison of cancer prevalence between groups
should be stratiﬁed by the working years.Guoxin Fan, MD
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